{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:18:47Z","timestamp":1783297127959,"version":"3.54.6"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.mcn.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T18:31:46Z","timestamp":1492799506000},"page":"23-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Ming","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiane","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina V.","family":"Vimbela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine B.","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Krotow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"de la Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2017.04.010_bb0005","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mcn.2017.04.010_bb0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11011-015-9719-4","article-title":"Characterization of prefrontal cortex microstructure and antioxidant status in a rat model of neurodegeneration induced by aluminium chloride and multiple low-dose streptozotocin","volume":"30","author":"Akinola","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac202383m","article-title":"Enhanced sensitivity for high spatial resolution lipid analysis by negative ion mode matrix assisted laser desorption ionization imaging mass spectrometry","volume":"84","author":"Angel","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1242\/dev.118.1.283","article-title":"Multiple extracellular signals are required for long-term oligodendrocyte survival","volume":"118","author":"Barres","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.mcn.2017.04.010_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","article-title":"Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease","volume":"25","author":"Bartzokis","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2017.04.010_bb0030","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1021\/cr200280p","article-title":"MALDI imaging of lipid biochemistry in tissues by mass spectrometry","volume":"111","author":"Berry","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mcn.2017.04.010_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2002-4312","article-title":"The role of the metabolic lesion in Alzheimer's disease","volume":"4","author":"Blass","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0040","first-page":"139","article-title":"Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?","volume":"46","author":"Blum-Degen","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.mcn.2017.04.010_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1383-5742(02)00044-3","article-title":"Genotoxicity of streptozotocin","volume":"512","author":"Bolzan","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0050","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.65.9.1202","article-title":"Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease","volume":"65","author":"Brickman","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002093-199505000-00008","article-title":"Rarefied white matter in patients with Alzheimer disease","volume":"9","author":"Brilliant","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.mcn.2017.04.010_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0278-5846(86)90009-6","article-title":"Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods","volume":"10","author":"Brun","year":"1986","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.mcn.2017.04.010_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410190306","article-title":"A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study","volume":"19","author":"Brun","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0070","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/archneur.62.12.1870","article-title":"White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease","volume":"62","author":"Burns","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0075","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/ac970888i","article-title":"Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS","volume":"69","author":"Caprioli","year":"1997","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2017.04.010_bb0085","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12031-008-9041-2","article-title":"Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS","volume":"35","author":"Chesik","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2017.04.010_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","article-title":"Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications","volume":"20","author":"Craft","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.mcn.2017.04.010_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0105","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/ac061768q","article-title":"Molecular profiling of native and matrix-coated tissue slices from rat brain by infrared and ultraviolet laser desorption\/ionization orthogonal time-of-flight mass spectrometry","volume":"79","author":"Dreisewerd","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12035-008-8022-3","article-title":"The role and metabolism of sulfatide in the nervous system","volume":"37","author":"Eckhardt","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0115","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.2329-07.2007","article-title":"Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy","volume":"27","author":"Eckhardt","year":"2007","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2017.04.010_bb0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000051183","article-title":"Neuropathology of white matter changes in Alzheimer's disease and vascular dementia","volume":"9","author":"Englund","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mcn.2017.04.010_bb0125","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1021\/ac201481r","article-title":"Analysis of native biological surfaces using a 100kV massive gold cluster source","volume":"83","author":"Fernandez-Lima","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mcn.2017.04.010_bb0135","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1039\/c2an36337b","article-title":"Lipid imaging by mass spectrometry - a review","volume":"138","author":"Gode","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.mcn.2017.04.010_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1041610296002736","article-title":"Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type","volume":"8","author":"Gottfries","year":"1996","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.mcn.2017.04.010_bb0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","article-title":"Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis","volume":"82","author":"Han","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2017.04.010_bb0155","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1044-0305(00)00172-0","article-title":"Characterization of phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate by electrospray ionization tandem mass spectrometry: a mechanistic study","volume":"11","author":"Hsu","year":"2000","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.mcn.2017.04.010_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2017.04.010_bb0165","series-title":"Sci STKE 2005","article-title":"Lipid microdomains and insulin resistance: is there a connection?","author":"Ikonen","year":"2005"},{"key":"10.1016\/j.mcn.2017.04.010_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jasms.2006.08.015","article-title":"In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS\/MS","volume":"18","author":"Jackson","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.mcn.2017.04.010_bb0175","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","article-title":"Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells","volume":"181","author":"Jeon","year":"2008","journal-title":"J. Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.mcn.2017.04.010_bb0180","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.mcn.2017.04.010_bb0185","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev.physiol.60.1.643","article-title":"Regulation of ceramide production and apoptosis","volume":"60","author":"Kolesnick","year":"1998","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-6143.2003.00040.x","article-title":"The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis)","volume":"3","author":"Koulmanda","year":"2003","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mcn.2017.04.010_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0200","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1471-4159.2010.06836.x","article-title":"Developmental profiling by mass spectrometry of phosphocholine containing phospholipids in the rat nervous system reveals temporo-spatial gradients","volume":"114","author":"Lohmann","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2017.04.010_bb0210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"Mehlhorn","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.mcn.2017.04.010_bb0215","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410250506","article-title":"Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease","volume":"25","author":"de la Monte","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","article-title":"Insulin resistance and Alzheimer's disease","volume":"42","author":"de la Monte","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.mcn.2017.04.010_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease","volume":"9","author":"de la Monte","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.mcn.2017.04.010_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","article-title":"Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for alzheimer's disease","volume":"77","author":"de la Monte","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.mcn.2017.04.010_bb0235","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer's disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0245","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease","volume":"10","author":"de la Monte","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0255","first-page":"1049","article-title":"Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis","volume":"10","author":"de la Monte","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.mcn.2017.04.010_bb0260","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3233\/JAD-2010-091726","article-title":"Ceramide-mediated insulin resistance and impairment of cognitive-motor functions","volume":"21","author":"de la Monte","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.mcn.2017.04.010_bb0265","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.3233\/JAD-2012-111728","article-title":"Dysfunctional pro-ceramide, ER stress, and insulin\/IGF signaling networks with progression of Alzheimer's disease","volume":"30","author":"de la Monte","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0270","first-page":"1","article-title":"Oligodendroglial and neuroglial molecular abnormalities in the intracerebral streptozotocin model of sporadic Alzheimer's Disease","volume":"1","author":"de la Monte","year":"2016","journal-title":"J Alzheimers Parkinsonism Dement."},{"key":"10.1016\/j.mcn.2017.04.010_bb0275","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-160656","article-title":"Improved brain insulin\/IGF signaling and reduced neuroinflammation with T3D-959 in an experimental model of sporadic Alzheimer's disease","volume":"55","author":"de la Monte","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2009-1158","article-title":"Neuropathology and the neuroinflammation idea","volume":"18","author":"Mrak","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0295","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2174\/1567205012666150710112618","article-title":"Mitochondrial deficits accompany cognitive decline following single bilateral intracerebroventricular streptozotocin","volume":"12","author":"Paidi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0300","series-title":"Myelin Formation, Structure and Biochemistry","author":"Quarles","year":"2006"},{"key":"10.1016\/j.mcn.2017.04.010_bb0305","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1523\/JNEUROSCI.2287-07.2007","article-title":"Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy","volume":"27","author":"Ramakrishnan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2017.04.010_bb0310","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0315","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1021\/bi026173d","article-title":"Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease","volume":"41","author":"Roher","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.mcn.2017.04.010_bb0320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-012-0877-9","article-title":"What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research","volume":"120","author":"Salkovic-Petrisic","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mcn.2017.04.010_bb0325","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/ac1029659","article-title":"Binary matrix for MALDI imaging mass spectrometry of phospholipids in both ion modes","volume":"83","author":"Shanta","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0330","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5099\/aj120100085","article-title":"The use of principal component analysis in MALDI-TOF MS: a powerful tool for establishing a mini-optimized proteomic profile","volume":"4","author":"Shao","year":"2012","journal-title":"Am. J. Biomed. Sci."},{"key":"10.1016\/j.mcn.2017.04.010_bb0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2990.2003.00456.x","article-title":"Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes","volume":"29","author":"Sjobeck","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0340","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/gps.1384","article-title":"Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease\u2014a neuropathological study","volume":"20","author":"Sjobeck","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.mcn.2017.04.010_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0350","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1074\/jbc.270.17.10187","article-title":"A neutral galactocerebroside sulfate sulfatidase from mouse brain","volume":"270","author":"Sundaram","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0355","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1194\/jlr.R026682","article-title":"Role of sulfatide in normal and pathological cells and tissues","volume":"53","author":"Takahashi","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0360","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcn.2017.04.010_bb0365","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-2009-0983","article-title":"Mechanisms of ceramide-mediated neurodegeneration","volume":"16","author":"Tong","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JAD-151013","article-title":"T3D-959: a multi-faceted disease remedial drug candidate for the treatment of Alzheimer's disease","volume":"51","author":"Tong","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2017.04.010_bb0375","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4172\/2161-0460.1000238","article-title":"Targeting Alzheimer's disease neuro-metabolic dysfunction with a small molecule nuclear receptor agonist (T3D-959) reverses disease pathologies","volume":"6","author":"Tong","year":"2016","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.mcn.2017.04.010_bb0380","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20050460","article-title":"Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes","volume":"391","author":"Vainio","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.mcn.2017.04.010_bb0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid beta oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2017.04.010_bb0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(94)90262-3","article-title":"Metabolic and functional aspects of sulfogalactolipids","volume":"1211","author":"Vos","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2017.04.010_bb0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neures.2003.10.002","article-title":"Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline","volume":"48","author":"Wang","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0400","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.metabol.2010.12.001","article-title":"Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo","volume":"60","author":"Wang","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.mcn.2017.04.010_bb0405","doi-asserted-by":"crossref","first-page":"796840","DOI":"10.1155\/2014\/796840","article-title":"Brain aging and AD-like pathology in streptozotocin-induced diabetic rats","volume":"2014","author":"Wang","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt103","article-title":"Lipidomics of Alzheimer's disease: current status","volume":"4","author":"Wood","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mcn.2017.04.010_bb0415","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1369\/0022155415596202","article-title":"Review of matrix-assisted laser desorption ionization-imaging mass spectrometry for lipid biochemical histopathology","volume":"63","author":"Yalcin","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mcn.2017.04.010_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4303\/jdar\/235928","article-title":"Differential lipid profiles in experimental steatohepatitis: role for imaging mass spectrometry as a diagnostic aid","volume":"4","author":"Yalcin","year":"2015","journal-title":"J. Drug Alcohol Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0425","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/acer.12909","article-title":"Differential sphingolipid and phospholipid profiles in alcohol and nicotine-derived nitrosamine ketone-associated white matter degeneration","volume":"39","author":"Yalcin","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.mcn.2017.04.010_bb0430","first-page":"1067","article-title":"Effect of Jiangtang Xiaozhi capsule on morphological changes of islet and liver in rat model [corrected] of type 2 diabetes [corrected] mellitus","volume":"33","author":"Yan","year":"2008","journal-title":"Zhongguo Zhong Yao Za Zhi"}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743116300793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743116300793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T18:27:27Z","timestamp":1719167247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743116300793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":86,"alternative-id":["S1044743116300793"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2017.04.010","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}